-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades Legend Biotech to Hold, Lowers Price Target to $21

Benzinga·01/22/2026 10:21:00
Listen to the news
TD Cowen analyst Yaron Werber downgrades Legend Biotech (NASDAQ:LEGN) from Buy to Hold and lowers the price target from $62 to $21.